GlassScriptPhysician profile
Dena Carl Hall
NPI 1689627341
$5,088.16
in general payments reported to CMS, 2019-2025
20 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $257 · 2021: $409 · 2022: $644 · 2023: $1,144 · 2024: $1,268 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,567.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,546.97 | 2019-2025 | Rocklatan, Eysuvis, Rhopressa |
| Johnson & Johnson Vision Care, INC. | $922.88 | 2019-2025 | Acuvue |
| Oyster Point Pharma, INC. | $382.01 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $339.86 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $329.14 | 2023-2025 | Infuse, Xiidra, Miebo |
| Abbvie INC. | $282.11 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $257.45 | 2019-2024 | Cequa |
| Tarsus Pharmaceuticals, INC. | $203.75 | 2024 | Xdemvy |
| Biotissue Holdings INC. | $191.56 | 2020-2025 | |
| Dompe US, INC. | $162.66 | 2021-2025 | Oxervate |
| Rxsight INC | $145.75 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Novartis Pharmaceuticals Corporation | $117.10 | 2019-2023 | |
| Maculogix, INC. | $77.80 | 2020 | |
| Glaukos Corporation | $25.06 | 2020 | |
| Genzyme Corporation | $25.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $19.63 | 2021 | |
| Abb Con-Cise Optical Group LLC | $17.42 | 2025 | Contact Lens, Spectacle Lenses |
| Coopervision INC. | $15.20 | 2019 | |
| Eyevance Pharmaceuticals LLC | $14.03 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.